Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study

Johanna M van Dongen, Saskia Persoon, Gabrielle Jongeneel, Judith E Bosmans, Marie José Kersten, Johannes Brug, Frans Nollet, Mai J M Chinapaw, Laurien M Buffart, Johanna M van Dongen, Saskia Persoon, Gabrielle Jongeneel, Judith E Bosmans, Marie José Kersten, Johannes Brug, Frans Nollet, Mai J M Chinapaw, Laurien M Buffart

Abstract

Purpose: To evaluate the long-term effectiveness and cost-effectiveness of a supervised 18-week high-intensity exercise program compared with usual care in patients treated with autologous stem cell transplantation.

Methods: One hundred nine patients were randomly assigned to the exercise intervention (n = 54) or the usual care control group (n = 55). Data on cardiorespiratory fitness (VO2peak), handgrip strength, general fatigue, and health-related quality of life (quality-adjusted life years [QALYs]) were collected at baseline (T0), after completion of the exercise intervention or at a similar time point in the control group (T1) and 12 months later (T2). Cost questionnaires were used to assess societal costs. Long-term effectiveness (at T2) was evaluated using linear mixed model analyses. For the economic evaluation, missing data were imputed using multiple imputation, and data were analyzed using linear mixed models.

Results: At T2, no statistically significant differences were found between the intervention and control group for VO2peak (0.12; 95%CI - 1.89; 2.14 ml/min/kg), handgrip strength (- 1.08; 95%CI- 2.47; 2.31), and general fatigue (- 0.69; 95%CI - 2.52; 1.14). During 12-months follow-up, no significant between-group differences in QALYs and societal costs were found (QALYs - 0.07; 95%CI - 0.17; 0.04; costs 529; 95%CI - 3205;4452). Intervention costs were €1340 per patient. For all outcomes, the probability of the intervention being cost-effective was low at reasonable values of willingness-to-pay.

Conclusion: We found no evidence for the exercise intervention being effective on physical fitness and fatigue, nor cost-effective from a societal perspective.

Trial registration: The study was prospectively registered on 27 May 2010 at the Netherlands Trial Register ( NTR2341 ).

Implications for cancer survivors: The current exercise intervention should not be recommended to patients recently treated with autologous stem cell transplantation.

Keywords: Cost-effectiveness; Exercise intervention; Long-term effectiveness; Lymphoma; Multiple myeloma.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow diagram of patients in the EXIST study
Fig. 2
Fig. 2
Cost-effectiveness planes indicating the uncertainty around the incremental cost-effectiveness ratios (1) and cost-effective acceptability curves indicating the probability of cost-effectiveness for different values (€) of willingness-to-pay per unit of effect gained (2) for cardiorespiratory fitness (a), handgrip strength (b), general fatigue (c), and health-related quality of life (d)

References

    1. Braam KI, van Dijk-Lokkart E, van Dongen J, van Litsenburg R, Takken T, Huisman J, et al. Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer: results from the quality of life in motion study. Eur J Cancer Care. 2017;26:e12586. doi: 10.1111/ecc.12586.
    1. Buffart L, Galvão DA, Brug J, Chinapaw M, Newton RU. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions. Cancer Treat Rev. 2014;40:327–340. doi: 10.1016/j.ctrv.2013.06.007.
    1. Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvão DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Lucia A, Mesters I, van Weert E, Knoop H, Goedendorp MM, Mutrie N, Daley AJ, McConnachie A, Bohus M, Thorsen L, Schulz KH, Short CE, James EL, Plotnikoff RC, Arbane G, Schmidt ME, Potthoff K, van Beurden M, Oldenburg HS, Sonke GS, van Harten WH, Garrod R, Schmitz KH, Winters-Stone KM, Velthuis MJ, Taaffe DR, van Mechelen W, Kersten MJ, Nollet F, Wenzel J, Wiskemann J, Verdonck-de Leeuw IM, Brug J. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104. doi: 10.1016/j.ctrv.2016.11.010.
    1. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane database of systematic reviews. 2008.
    1. De Backer IC, Schep G, Hoogeveen A, Vreugdenhil G, Kester AD, van Breda E. Exercise testing and training in a cancer rehabilitation program: the advantage of the steep ramp test. Arch Phys Med Rehabil. 2007;88:610–616. doi: 10.1016/j.apmr.2007.02.013.
    1. Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12:409–418. doi: 10.1111/j.1524-4733.2008.00489.x.
    1. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015.
    1. EuroQol G. EuroQol--a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands) 1990;16:199. doi: 10.1016/0168-8510(90)90421-9.
    1. Fuller JT, Hartland MC, Maloney LT, Davison K. Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of meta-analyses of clinical trials. Br J Sports Med. 2018:bjsports–2017-098285.
    1. Gao L, Moodie M, Brown V, Avery S. Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation. Clin Transpl. 2017;31:e13049. doi: 10.1111/ctr.13049.
    1. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081–1093. doi: 10.1161/CIRCULATIONAHA.107.185649.
    1. Kampshoff C, van Dongen J, van Mechelen W, Schep G, Vreugdenhil A, Twisk J, et al. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors. J Cancer Surviv. 2018;12:417–429. doi: 10.1007/s11764-018-0681-0.
    1. Knols R, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, et al. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant. 2011;46:1245–1255. doi: 10.1038/bmt.2010.288.
    1. Lamers L, Stalmeier P, McDonnell J, Krabbe P. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd. 2005;149:1574–1578.
    1. Levinger I, Goodman C, Hare DL, Jerums G, Toia D, Selig S. The reliability of the 1RM strength test for untrained middle-aged individuals. J Sci Med Sport. 2009;12:310–316. doi: 10.1016/j.jsams.2007.10.007.
    1. Liang Y, Zhou M, Wang F, Wu Z. Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials. Jpn J Clin Oncol. 2018;48:1046–1057. doi: 10.1093/jjco/hyy144.
    1. May AM, Bosch MJ, Velthuis MJ, Van Der Wall E, Bisschop CNS, Los M, et al. Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017;7:e012187. doi: 10.1136/bmjopen-2016-012187.
    1. Mewes J. C., Steuten L. M. G., IJzerman M. J., van Harten W. H. Effectiveness of Multidimensional Cancer Survivor Rehabilitation and Cost-Effectiveness of Cancer Rehabilitation in General: A Systematic Review. The Oncologist. 2012;17(12):1581–1593. doi: 10.1634/theoncologist.2012-0151.
    1. Mewes JC, Steuten LM, Duijts SF, Oldenburg HS, van Beurden M, Stuiver MM, et al. Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv. 2015;9:126–135. doi: 10.1007/s11764-014-0396-9.
    1. Oberoi S, Robinson PD, Cataudella D, Culos-Reed SN, Davis H, Duong N, Gibson F, Götte M, Hinds P, Nijhof SL, Tomlinson D, van der Torre P, Cabral S, Dupuis LL, Sung L. Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hematol. 2018;122:52–59. doi: 10.1016/j.critrevonc.2017.12.011.
    1. Persoon S, Kersten MJ, ChinAPaw MJ, Buffart LM, Burghout H, Schep G, et al. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. BMC Cancer. 2010;10:671. doi: 10.1186/1471-2407-10-671.
    1. Persoon S, Kersten MJ, van der Weiden K, Buffart LM, Nollet F, Brug J, Chinapaw MJM. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treat Rev. 2013;39:682–690. doi: 10.1016/j.ctrv.2013.01.001.
    1. Persoon S, ChinAPaw MJ, Buffart LM, Liu RD, Wijermans P, Koene HR, et al. Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: results from the EXIST study. PLoS One. 2017;12:e0181313. doi: 10.1371/journal.pone.0181313.
    1. Persoon S, Kersten MJ, Buffart LM, Vander Slagmolen G, Baars JW, Visser O, Manenschijn A, Nollet F, Chinapaw MJM. Health-related physical fitness in patients with multiple myeloma or lymphoma recently treated with autologous stem cell transplantation. J Sci Med Sport. 2017;20:116–122. doi: 10.1016/j.jsams.2016.01.006.
    1. Persoon S, Chinapaw M, Buffart L, Brug J, Kersten M, Nollet F. Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation. Eur J Cancer Care. 2018;27:e12779. doi: 10.1111/ecc.12779.
    1. Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD. Cost-effectiveness analysis alongside clinical trials II-an ISPOR good research practices task force report. Value Health. 2015;18(2):161–172. doi: 10.1016/j.jval.2015.02.001.
    1. Roseboom KJ, van Dongen JM, Tompa E, van Tulder MW, Bosmans JE. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators. BMC Health Serv Res. 2017;17:89. doi: 10.1186/s12913-017-1986-9.
    1. Segal R, Zwaal C, Green E, Tomasone J, Loblaw A, Petrella T. Exercise for people with cancer: a systematic review. Curr Oncol. 2017;24:e290. doi: 10.3747/co.24.3519.
    1. Smets E.M.A., Garssen B., Bonke B., De Haes J.C.J.M. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research. 1995;39(3):315–325. doi: 10.1016/0022-3999(94)00125-O.
    1. Sweegers MG, Altenburg TM, Chinapaw MJ, Kalter J, Verdonck-de Leeuw IM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Brug J, Buffart LM. Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2018;52:505–513. doi: 10.1136/bjsports-2017-097891.
    1. Tan SS, Bouwmans-Frijters CA, Hakkaart-van Roijen L. Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg. Tijdschrift voor gezondheidswetenschappen. 2012;90:367–372. doi: 10.1007/s12508-012-0128-3.
    1. Travier N, Velthuis MJ, Bisschop CNS, van den Buijs B, Monninkhof EM, Backx F, et al. Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. BMC Med. 2015;13:121. doi: 10.1186/s12916-015-0362-z.
    1. Van Der Meer EW, van Dongen JM, Boot CR, van der Gulden JW, Bosmans JE, Anema JR. Economic evaluation of a multifaceted implementation strategy for the prevention of hand eczema among healthcare workers in comparison with a control group: the Hands4U study. Acta Derm Venereol. 2016;96:499–504. doi: 10.2340/00015555-2287.
    1. van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK. Effect of low-intensity physical activity and moderate-to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33:1918–1927. doi: 10.1200/JCO.2014.59.1081.
    1. van Waart H, van Dongen JM, van Harten WH, Stuiver MM, Huijsmans R, Hellendoorn-van Vreeswijk JA, et al. Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy. Eur J Health Econ. 2018;19:893–904. doi: 10.1007/s10198-017-0936-0.
    1. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi: 10.1002/sim.4067.
    1. Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ. 2004;13(5):461–475. doi: 10.1002/hec.843.

Source: PubMed

3
Suscribir